SEARCH:   Advanced

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Willemze, R. Articles by Meijer, C.J.L.M. Search for Related Content PubMed PubMed Citation Articles by Willemze, R. Articles by Meijer, C.J.L.M. Related Collections Neoplasia Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer R. Willemze, H. Kerl, W. Sterry, E. Berti, L. Cerroni, S. Chimenti, J.L. Diaz-Peréz, M.L. Geerts, M. Goos, R. Knobler, E. Ralfkiaer, M. Santucci, N. Smith, J. Wechsler, W.A. van Vloten, and C.J.L.M. Meijer From the Departments of Dermatology and Pathology, Free University Hospital, Amsterdam, The Netherlands; the Department of Dermatology, University of Graz, Austria; the Department of Dermatology, Charité, Humboldt University, Berlin, Germany; the Department of Dermatology, University of Milan, Italy; the Department of Dermatology, University of L'Aquila, Italy; the Department of Dermatology, Cruces Hospital, Bilbao, Spain; the Department of Dermatology, University of Gent, Belgium; the Department of Dermatology, University of Essen, Germany; the Department of Dermatology, University of Vienna, Austria; the Department of Pathology, Herlev Hospital, University of Copenhagen, Denmark; the Department of Pathology, University of Florence, Italy; the Department of Dermatology, St John's Hospital, London, UK; the Department of Pathology, Hospital Henri Mondor, Paris, France; the Department of Dermatology, University of Utrecht, The Netherlands. Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas that show considerable variation in histology, phenotype, and prognosis. Recently, the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group has reached consensus on a new classification for this group of diseases. The EORTC classification for primary cutaneous lymphomas is based on a combination of clinical, histologic, and immunophenotypic criteria, and thus contains well-defined disease entities rather than histologic subgroups. In addition, this new classification contains a number of provisional entities, which may display characteristic histologic features, but are not yet well defined clinically. These provisional entities account for less than 5% of all primary cutaneous lymphomas. In this report the basic principles of this new classification, as well as the characteristic features of the different disease entities, are described. In addition, survival data of 626 patients with primary cutaneous lymphomas derived from the registry of the Dutch Cutaneous Lymphoma Working Group, illustrating the clinical validity of this new classification, are presented. Blood, Vol. 90 No. 1 (July 1), 1997: pp. 354-371 © 1997 by The American Society of Hematology. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: H. M. Prince, S. Whittaker, and R. T. Hoppe How I treat mycosis fungoides and Sezary syndrome Blood, November 12, 2009; 114(20): 4337 - 4353. [Abstract] [Full Text] [PDF] F. Grange and F. Antonicelli Cutaneous Lymphomas: What Can We Learn From Location? Arch Dermatol, June 1, 2009; 145(6): 710 - 712. [Full Text] [PDF] P. Chandra, J. A. Plaza, Z. Zuo, A. H. Diwan, H. Koeppen, M. Duvic, L. J. Medeiros, and V. G. Prieto Clusterin Expression Correlates With Stage and Presence of Large Cells in Mycosis Fungoides Am J Clin Pathol, April 1, 2009; 131(4): 511 - 515. [Abstract] [Full Text] [PDF] W. Kempf, S. Ostheeren-Michaelis, M. Paulli, M. Lucioni, J. Wechsler, H. Audring, C. Assaf, T. Rudiger, R. Willemze, C. J. L. M. Meijer, et al. Granulomatous Mycosis Fungoides and Granulomatous Slack Skin: A Multicenter Study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization for Research and Treatment of Cancer (EORTC) Arch Dermatol, December 1, 2008; 144(12): 1609 - 1617. [Abstract] [Full Text] [PDF] A. Garcia-Herrera, L. Colomo, M. Camos, J. Carreras, O. Balague, A. Martinez, A. Lopez-Guillermo, T. Estrach, and E. Campo Primary Cutaneous Small/Medium CD4+ T-Cell Lymphomas: A Heterogeneous Group of Tumors With Different Clinicopathologic Features and Outcome J. Clin. Oncol., July 10, 2008; 26(20): 3364 - 3371. [Abstract] [Full Text] [PDF] G. Quereux, S. Marques, J.-M. Nguyen, C. Bedane, M. D'incan, O. Dereure, E. Puzenat, A. Claudy, L. Martin, P. Joly, et al. Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sezary Syndrome Arch Dermatol, June 1, 2008; 144(6): 727 - 733. [Abstract] [Full Text] [PDF] W. Sterry and L. Heinzerling Clinical Research in Cutaneous T-Cell Lymphoma Moving Forward Arch Dermatol, June 1, 2008; 144(6): 786 - 787. [Full Text] [PDF] R. Willemze, P. M. Jansen, L. Cerroni, E. Berti, M. Santucci, C. Assaf, M. R. Canninga-van Dijk, A. Carlotti, M.-L. Geerts, S. Hahtola, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases Blood, January 15, 2008; 111(2): 838 - 845. [Abstract] [Full Text] [PDF] N. J. Senff, J. J. Hoefnagel, K. J. Neelis, M. H. Vermeer, E. M. Noordijk, R. Willemze, and for the Dutch Cutaneous Lymphoma Group Results of Radiotherapy in 153 Primary Cutaneous B-Cell Lymphomas Classified According to the WHO-EORTC Classification Arch Dermatol, December 1, 2007; 143(12): 1520 - 1526. [Abstract] [Full Text] [PDF] P. L. Zinzani, G. Musuraca, M. Tani, V. Stefoni, E. Marchi, M. Fina, C. Pellegrini, L. Alinari, E. Derenzini, A. de Vivo, et al. Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma J. Clin. Oncol., September 20, 2007; 25(27): 4293 - 4297. [Abstract] [Full Text] [PDF] F. Grange, M. Beylot-Barry, P. Courville, E. Maubec, M. Bagot, B. Vergier, P. Souteyrand, L. Machet, S. Dalac, E. Esteve, et al. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Clinicopathologic Features and Prognostic Analysis in 60 Cases Arch Dermatol, September 1, 2007; 143(9): 1144 - 1150. [Abstract] [Full Text] [PDF] A. Marie-Cardine, D. Huet, N. Ortonne, N. Remtoula, S. L. Gouvello, M. Bagot, and A. Bensussan Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome Blood, June 1, 2007; 109(11): 5064 - 5065. [Full Text] [PDF] M. Martusewicz-Boros, E. Wiatr, E. Radzikowska, K. Roszkowski-Sliz, and R. Langfort Pulmonary Intravascular Large B-Cell Lymphoma As a Cause of Severe Hypoxemia J. Clin. Oncol., May 20, 2007; 25(15): 2137 - 2139. [Full Text] [PDF] N. J. Senff, J. J. Hoefnagel, P. M. Jansen, M. H. Vermeer, J. van Baarlen, W. A. Blokx, M. R. Canninga-van Dijk, M.-L. Geerts, K. M. Hebeda, P. M. Kluin, et al. Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO-EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers J. Clin. Oncol., April 20, 2007; 25(12): 1581 - 1587. [Abstract] [Full Text] [PDF] P. V. Cabrera, M. Amano, J. Mitoma, J. Chan, J. Said, M. Fukuda, and L. G. Baum Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death Blood, October 1, 2006; 108(7): 2399 - 2406. [Abstract] [Full Text] [PDF] M. Nebozhyn, A. Loboda, L. Kari, A. H. Rook, E. C. Vonderheid, S. Lessin, C. Berger, R. Edelson, C. Nichols, M. Yousef, et al. Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy Blood, April 15, 2006; 107(8): 3189 - 3196. [Abstract] [Full Text] [PDF] P. L. Zinzani, P. Quaglino, N. Pimpinelli, E. Berti, G. Baliva, S. Rupoli, M. Martelli, M. Alaibac, G. Borroni, S. Chimenti, et al. Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas J. Clin. Oncol., March 20, 2006; 24(9): 1376 - 1382. [Abstract] [Full Text] [PDF] R. Dijkman, C. P. Tensen, E. S. Jordanova, J. Knijnenburg, J. J. Hoefnagel, A. A. Mulder, C. Rosenberg, A. K. Raap, R. Willemze, K. Szuhai, et al. Array-Based Comparative Genomic Hybridization Analysis Reveals Recurrent Chromosomal Alterations and Prognostic Parameters in Primary Cutaneous Large B-Cell Lymphoma J. Clin. Oncol., January 10, 2006; 24(2): 296 - 305. [Abstract] [Full Text] [PDF] D. Huet, M. Bagot, D. Loyaux, J. Capdevielle, L. Conraux, P. Ferrara, A. Bensussan, and A. Marie-Cardine SC5 mAb Represents a Unique Tool for the Detection of Extracellular Vimentin as a Specific Marker of Sezary Cells J. Immunol., January 1, 2006; 176(1): 652 - 659. [Abstract] [Full Text] [PDF] K. Kodama, C. Massone, A. Chott, D. Metze, H. Kerl, and L. Cerroni Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients Blood, October 1, 2005; 106(7): 2491 - 2497. [Abstract] [Full Text] [PDF] T. Juarez, S. N. Isenhath, N. L. Polissar, D. E. Sabath, B. Wood, D. Hanke, C. L. Haycox, G. S. Wood, and J. E. Olerud Analysis of T-Cell Receptor Gene Rearrangement for Predicting Clinical Outcome in Patients With Cutaneous T-Cell Lymphoma: A Comparison of Southern Blot and Polymerase Chain Reaction Methods Arch Dermatol, September 1, 2005; 141(9): 1107 - 1113. [Abstract] [Full Text] [PDF] J. J. Hoefnagel, M. H. Vermeer, P. M. Jansen, F. Heule, P. C. van Voorst Vader, C. J. G. Sanders, M. J. P. Gerritsen, M. L. Geerts, C. J. L. M. Meijer, E. M. Noordijk, et al. Primary Cutaneous Marginal Zone B-Cell Lymphoma: Clinical and Therapeutic Features in 50 Cases Arch Dermatol, September 1, 2005; 141(9): 1139 - 1145. [Abstract] [Full Text] [PDF] R. van Doorn, W. H. Zoutman, R. Dijkman, R. X. de Menezes, S. Commandeur, A. A. Mulder, P. A. van der Velden, M. H. Vermeer, R. Willemze, P. S. Yan, et al. Epigenetic Profiling of Cutaneous T-Cell Lymphoma: Promoter Hypermethylation of Multiple Tumor Suppressor Genes Including BCL7a, PTPRG, and p73 J. Clin. Oncol., June 10, 2005; 23(17): 3886 - 3896. [Abstract] [Full Text] [PDF] B. D. Smith, G. L. Smith, D. L. Cooper, and L. D. Wilson The Cutaneous B-Cell Lymphoma Prognostic Index: A Novel Prognostic Index Derived From a Population-Based Registry J. Clin. Oncol., May 20, 2005; 23(15): 3390 - 3395. [Abstract] [Full Text] [PDF] M. E. Kadin Latest lymphoma classification is skin deep Blood, May 15, 2005; 105(10): 3759 - 3759. [Full Text] [PDF] R. Willemze, E. S. Jaffe, G. Burg, L. Cerroni, E. Berti, S. H. Swerdlow, E. Ralfkiaer, S. Chimenti, J. L. Diaz-Perez, L. M. Duncan, et al. WHO-EORTC classification for cutaneous lymphomas Blood, May 15, 2005; 105(10): 3768 - 3785. [Abstract] [Full Text] [PDF] J. J. Hoefnagel, R. Dijkman, K. Basso, P. M. Jansen, C. Hallermann, R. Willemze, C. P. Tensen, and M. H. Vermeer Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling Blood, May 1, 2005; 105(9): 3671 - 3678. [Abstract] [Full Text] [PDF] C. Querfeld, S. T. Rosen, T. M. Kuzel, K. A. Kirby, H. H. Roenigk Jr, B. M. Prinz, and J. Guitart Long-term Follow-up of Patients With Early-Stage Cutaneous T-Cell Lymphoma Who Achieved Complete Remission With Psoralen Plus UV-A Monotherapy Arch Dermatol, March 1, 2005; 141(3): 305 - 311. [Abstract] [Full Text] [PDF] N. Franck, A. Carlotti, I. Gorin, M. Buffet, C. Mateus, N. Dupin, and for the French Study Group on Cutaneous Lymphomas Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma and Neutrophilic Dermatosis Arch Dermatol, March 1, 2005; 141(3): 353 - 356. [Abstract] [Full Text] [PDF] S M Winhoven, S Murugesan, and I H Coulson Solitary CD30+ anaplastic large cell lymphoma of the eyelid showing regression Br J Ophthalmol, March 1, 2005; 89(3): 385 - 385. [Full Text] [PDF] C. Assaf, M. Hummel, M. Steinhoff, C. C. Geilen, H. Orawa, H. Stein, and C. E. Orfanos Early TCR-{beta} and TCR-{gamma} PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications Blood, January 15, 2005; 105(2): 503 - 510. [Abstract] [Full Text] [PDF] C Assaf, M Hummel, M Zemlin, M Steinhoff, C C Geilen, H Stein, and C E Orfanos Transition of Sezary syndrome into mycosis fungoides after complete clinical and molecular remission under extracorporeal photophoresis J. Clin. Pathol., December 1, 2004; 57(12): 1325 - 1328. [Abstract] [Full Text] [PDF] R. Dummer, J. C. Hassel, F. Fellenberg, S. Eichmuller, T. Maier, P. Slos, B. Acres, P. Bleuzen, V. Bataille, P. Squiban, et al. Adenovirus-mediated intralesional interferon-{gamma} gene transfer induces tumor regressions in cutaneous lymphomas Blood, September 15, 2004; 104(6): 1631 - 1638. [Abstract] [Full Text] [PDF] E. Tancrede-Bohin, M. A. Ionescu, P. de La Salmoniere, A. Dupuy, J. Rivet, M. Rybojad, L. Dubertret, H. Bachelez, C. Lebbe, and P. Morel Prognostic Value of Blood Eosinophilia in Primary Cutaneous T-Cell Lymphomas Arch Dermatol, September 1, 2004; 140(9): 1057 - 1061. [Abstract] [Full Text] [PDF] R. van Doorn, R. Dijkman, M. H. Vermeer, J. J. Out-Luiting, E. M. H. van der Raaij-Helmer, R. Willemze, and C. P. Tensen Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sezary Syndrome Identified by Gene Expression Analysis Cancer Res., August 15, 2004; 64(16): 5578 - 5586. [Abstract] [Full Text] [PDF] M. W. Bekkenk, P. M. Jansen, C. J. L. M. Meijer, and R. Willemze CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature Ann. Onc., July 1, 2004; 15(7): 1097 - 1108. [Abstract] [Full Text] [PDF] Rhinophymalike Swelling in an 86-Year-Old Woman--Diagnosis Arch Dermatol, June 1, 2004; 140(6): 751 - 751. [Full Text] [PDF] F. Grange, T. Petrella, M. Beylot-Barry, P. Joly, M. D'Incan, M. Delaunay, L. Machet, M.-F. Avril, S. Dalac, P. Bernard, et al. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas Blood, May 15, 2004; 103(10): 3662 - 3668. [Abstract] [Full Text] [PDF] M. Girardi, P. W. Heald, and L. D. Wilson The Pathogenesis of Mycosis Fungoides N. Engl. J. Med., May 6, 2004; 350(19): 1978 - 1988. [Full Text] [PDF] Lymphomatoid Papulosis: Reappraisal of Clinicopathologic Presentation and Classification Into Subtypes A, B, and C Arch Dermatol, April 1, 2004; 140(4): 441 - 447. CD30+ Cutaneous Lymphoma in Association With Atopic Eczema Arch Dermatol, April 1, 2004; 140(4): 449 - 454. Widespread Recurrent Lichenoid Papular Eruption--Diagnosis Arch Dermatol, April 1, 2004; 140(4): 479 - 484. T. Nijsten, C. Curiel-Lewandrowski, and M. E. Kadin Lymphomatoid Papulosis in Children: A Retrospective Cohort Study of 35 Cases Arch Dermatol, March 1, 2004; 140(3): 306 - 312. [Abstract] [Full Text] [PDF] B. D. Smith, E. J. Glusac, J. M. McNiff, G. L. Smith, P. W. Heald, D. L. Cooper, and L. D. Wilson Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems J. Clin. Oncol., February 15, 2004; 22(4): 634 - 639. [Abstract] [Full Text] [PDF] F. M. Raaphorst, M. Vermeer, E. Fieret, T. Blokzijl, D. Dukers, R. G.A.B. Sewalt, A. P. Otte, R. Willemze, and C. J.L.M. Meijer Site-Specific Expression of Polycomb-Group Genes Encoding the HPC-HPH/PRC1 Complex in Clinically Defined Primary Nodal and Cutaneous Large B-Cell Lymphomas Am. J. Pathol., February 1, 2004; 164(2): 533 - 542. [Abstract] [Full Text] [PDF] J F Blaikley, P Atkinson, and M K Almond Cutaneous T-cell lymphoma with adrenal insufficiency J R Soc Med, October 1, 2003; 96(10): 503 - 504. [Full Text] [PDF] T. Maier, A. Tun-Kyi, A. Tassis, K.-P. Jungius, G. Burg, R. Dummer, and F. O. Nestle Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells Blood, October 1, 2003; 102(7): 2338 - 2344. [Abstract] [Full Text] [PDF] M. W. Bekkenk, M. H. Vermeer, P. M. Jansen, A. M. W. van Marion, M. R. Canninga-van Dijk, P. M. Kluin, M.-L. Geerts, C. J. L. M. Meijer, and R. Willemze Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients Blood, September 15, 2003; 102(6): 2213 - 2219. [Abstract] [Full Text] [PDF] D. Winter, E. Fiebiger, P. Meraner, H. Auer, C. Brna, R. Strohal, F. Trautinger, R. Knobler, G. F. Fischer, G. Stingl, et al. Definition of TCR Epitopes for CTL-Mediated Attack of Cutaneous T Cell Lymphoma J. Immunol., September 1, 2003; 171(5): 2714 - 2724. [Abstract] [Full Text] [PDF] R. H. Weenig and M. R. Pittelkow Cutaneous T-Cell Lymphoma Mayo Clin. Proc., August 1, 2003; 78(8): 1054 - 1055. [PDF] J. R. Toro, D. J. Liewehr, N. Pabby, L. Sorbara, M. Raffeld, S. M. Steinberg, and E. S. Jaffe Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma Blood, May 1, 2003; 101(9): 3407 - 3412. [Abstract] [Full Text] [PDF] M. Kleinhans, A. Tun-Kyi, M. Gilliet, M. E. Kadin, R. Dummer, G. Burg, and F. O. Nestle Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma Blood, February 15, 2003; 101(4): 1487 - 1493. [Abstract] [Full Text] [PDF] X. Mao, G. Orchard, D. M. Lillington, R. Russell-Jones, B. D. Young, and S. J. Whittaker Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas Blood, February 15, 2003; 101(4): 1513 - 1519. [Abstract] [Full Text] [PDF] W. Kempf, M. E. Kadin, A. M. Dvorak, C. C. Lord, G. Burg, N. L. Letvin, and I. J. Koralnik Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin Carcinogenesis, February 1, 2003; 24(2): 301 - 306. [Full Text] [PDF] R. van Doorn, R. Dijkman, M. H. Vermeer, T. M. Starink, R. Willemze, and C. P. Tensen A Novel Splice Variant of the Fas Gene in Patients with Cutaneous T-Cell Lymphoma Cancer Res., October 1, 2002; 62(19): 5389 - 5392. [Abstract] [Full Text] [PDF] C. Visco, L. J. Medeiros, D. Jones, T. Smith, M. A. Rodriguez, P. McLaughlin, J. Romaguera, F. Cabanillas, and A. H. Sarris Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement Ann. Onc., August 1, 2002; 13(8): 1290 - 1299. [Abstract] [Full Text] [PDF] M. Nikolova, P. Musette, M. Bagot, L. Boumsell, and A. Bensussan Engagement of ILT2/CD85j in Sezary syndrome cells inhibits their CD3/TCR signaling Blood, July 18, 2002; 100(3): 1019 - 1025. [Abstract] [Full Text] [PDF] M. Steinhoff, M. Hummel, I. Anagnostopoulos, P. Kaudewitz, V. Seitz, C. Assaf, C. Sander, and H. Stein Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin Blood, June 28, 2002; 100(2): 578 - 584. [Abstract] [Full Text] [PDF] R Goyal, R J Motley, S D Dojcinov, and C M Lane Cutaneous presentation of orbital follicular lymphoma: clinical differential diagnosis with lymphocytoma cutis Br J Ophthalmol, May 1, 2002; 86(5): 596 - 597. [Full Text] [PDF] D. Breneman, M. Duvic, T. Kuzel, R. Yocum, J. Truglia, and V. J. Stevens Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell Lymphoma Arch Dermatol, March 1, 2002; 138(3): 325 - 332. [Abstract] [Full Text] [PDF] I. Mirza, N. Macpherson, S. Paproski, R. D. Gascoyne, B. Yang, W. G. Finn, and E. D. Hsi Primary Cutaneous Follicular Lymphoma: An Assessment of Clinical, Histopathologic, Immunophenotypic, and Molecular Features J. Clin. Oncol., February 1, 2002; 20(3): 647 - 655. [Abstract] [Full Text] [PDF] L. Cerroni, R. Fink-Puches, B. Back, and H. Kerl Follicular Mucinosis: A Critical Reappraisal of Clinicopathologic Features and Association With Mycosis Fungoides and Sezary Syndrome Arch Dermatol, February 1, 2002; 138(2): 182 - 189. [Abstract] [Full Text] [PDF] R. van Doorn, E. Scheffer, R. Willemze, and for the Dutch Cutaneous Lymphoma Group Follicular Mycosis Fungoides, a Distinct Disease Entity With or Without Associated Follicular Mucinosis: A Clinicopathologic and Follow-up Study of 51 Patients Arch Dermatol, February 1, 2002; 138(2): 191 - 198. [Abstract] [Full Text] [PDF] R. Dummer, J. Kamarashev, W. Kempf, A. C. Haffner, M. Hess-Schmid, and G. Burg Junctional CD8+ Cutaneous Lymphomas With Nonaggressive Clinical Behavior: A CD8+ Variant of Mycosis Fungoides? Arch Dermatol, February 1, 2002; 138(2): 199 - 203. [Abstract] [Full Text] [PDF] R. Fink-Puches, P. Zenahlik, B. Back, J. Smolle, H. Kerl, and L. Cerroni Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients Blood, February 1, 2002; 99(3): 800 - 805. [Abstract] [Full Text] [PDF] M. Urosevic, J. Willers, B. Mueller, W. Kempf, G. Burg, and R. Dummer HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas Blood, January 15, 2002; 99(2): 609 - 617. [Abstract] [Full Text] [PDF] J. M. Connors, E. D. Hsi, and F. M. Foss Lymphoma of the Skin Hematology, January 1, 2002; 2002(1): 263 - 282. [Abstract] [Full Text] M. H. Vermeer, R. van Doorn, D. Dukers, M. W. Bekkenk, C. J.L.M. Meijer, and R. Willemze CD8+ T Cells in Cutaneous T-Cell Lymphoma: Expression of Cytotoxic Proteins, Fas Ligand, and Killing Inhibitory Receptors and Their Relationship With Clinical Behavior J. Clin. Oncol., December 1, 2001; 19(23): 4322 - 4329. [Abstract] [Full Text] N. V. Kamath, A. C. Gilliam, M. Nihal, T. P. Spiro, and G. S. Wood Primary Cutaneous Large B-Cell Lymphoma of the Leg Relapsing as Cutaneous Intravascular Large B-Cell Lymphoma Arch Dermatol, December 1, 2001; 137(12): 1657 - 1658. [Full Text] [PDF] K. D. Berg, N. K. Brinster, K. M. Huhn, M. G. Goggins, R. J. Jones, A. Makary, K. M. Murphy, C. A. Griffin, L. S. Rosenblum-Vos, M. J. Borowitz, et al. Transmission of a T-Cell Lymphoma by Allogeneic Bone Marrow Transplantation N. Engl. J. Med., November 15, 2001; 345(20): 1458 - 1463. [Full Text] [PDF] G. S. Wood T-Cell Receptor and Immunoglobulin Gene Rearrangements in Diagnosing Skin Disease Arch Dermatol, November 1, 2001; 137(11): 1503 - 1506. [Full Text] [PDF] R. L. Piekarz, R. Robey, V. Sandor, S. Bakke, W. H. Wilson, L. Dahmoush, D. M. Kingma, M. L. Turner, R. Altemus, and S. E. Bates Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report Blood, November 1, 2001; 98(9): 2865 - 2868. [Abstract] [Full Text] [PDF] F. Grange, M. W. Bekkenk, J. Wechsler, C. J.L.M. Meijer, L. Cerroni, M. Bernengo, J. Bosq, G. Hedelin, R. Fink Puches, W. A. van Vloten, et al. Prognostic Factors in Primary Cutaneous Large B-Cell Lymphomas: A European Multicenter Study J. Clin. Oncol., August 15, 2001; 19(16): 3602 - 3610. [Abstract] [Full Text] [PDF] M. H. Vermeer, C. P. Tensen, P. M. van der Stoop, H. W. van Oostveen, M. Lund, R. J. Scheper, and R. Willemze Absence of TH2 Cytokine Messenger RNA Expression in CD30-Negative Primary Cutaneous Large T-Cell Lymphomas Arch Dermatol, July 1, 2001; 137(7): 901 - 905. [Abstract] [Full Text] [PDF] P. Rubegni, G. De Aloe, M. Di Renzo, G. Pompella, A. L. Pasqui, A. Auteri, L. Andreassi, and M. Fimiani Cytokine Production Profile of Peripheral Blood Mononuclear Cells in Patients With Large-Plaque Parapsoriasis Arch Dermatol, July 1, 2001; 137(7): 966 - 967. [Full Text] [PDF] J. Kamarashev, G. Burg, M. C. Mingari, W. Kempf, G. Hofbauer, and R. Dummer Differential Expression of Cytotoxic Molecules and Killer Cell Inhibitory Receptors in CD8+ and CD56+ Cutaneous Lymphomas Am. J. Pathol., May 1, 2001; 158(5): 1593 - 1598. [Abstract] [Full Text] [PDF] R. Bergman, P. J. Kurtin, L. E. Gibson, P. R. Hull, T. K. Kimlinger, and A. L. Schroeter Clinicopathologic, Immunophenotypic, and Molecular Characterization of Primary Cutaneous Follicular B-Cell Lymphoma Arch Dermatol, April 1, 2001; 137(4): 432 - 439. [Abstract] [Full Text] [PDF] L. Cerroni and H. Kerl Primary Cutaneous Follicular Lymphoma Arch Dermatol, April 1, 2001; 137(4): 489 - 490. [Full Text] [PDF] D F Dukers, M H Vermeer, L H Jaspars, C A Sander, M J Flaig, W Vos, R Willemze, and C J L M Meijer Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype J. Clin. Pathol., March 1, 2001; 54(3): 224 - 228. [Abstract] [Full Text] [PDF] M. Bagot, A. Moretta, S. Sivori, R. Biassoni, C. Cantoni, C. Bottino, L. Boumsell, and A. Bensussan CD4+ cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor Blood, March 1, 2001; 97(5): 1388 - 1391. [Abstract] [Full Text] [PDF] T. E. Hansen-Hagge, U. Trefzer, A. S. zu Reventlow, K. Kaltoft, and W. Sterry Identification of sample-specific sequences in mammalian cDNA and genomic DNA by the novel ligation-mediated subtraction (Limes) Nucleic Acids Res., February 15, 2001; 29(4): e20 - e20. [Abstract] [Full Text] [PDF] J. J. Scarisbrick, S. Whittaker, A. V. Evans, E. A. Fraser-Andrews, F. J. Child, A. Dean, and R. Russell-Jones Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma Blood, February 1, 2001; 97(3): 624 - 630. [Abstract] [Full Text] [PDF] A. H. Sarris, I. Braunschweig, L. J. Medeiros, M. Duvic, C. S. Ha, M. A. Rodriguez, F. B. Hagemeister, P. McLaughlin, J. Romaguera, J. Cox, et al. Primary Cutaneous Non-Hodgkin's Lymphoma of Ann Arbor Stage I: Preferential Cutaneous Relapses but High Cure Rate With Doxorubicin-Based Therapy J. Clin. Oncol., January 15, 2001; 19(2): 398 - 405. [Abstract] [Full Text] [PDF] D. Slater Histopathological aspects of cutaneous lymphoma J R Soc Med, January 7, 2001; 94(7): 337 - 340. [Full Text] [PDF] M. Storz, K. Zepter, J. Kamarashev, R. Dummer, G. Burg, and A. C. Häffner Coexpression of CD40 and CD40 Ligand in Cutaneous T-Cell Lymphoma (Mycosis Fungoides) Cancer Res., January 1, 2001; 61(2): 452 - 454. [Abstract] [Full Text] J. P. Greer, M. C. Kinney, and T. P. Loughran Jr. T Cell and NK Cell Lymphoproliferative Disorders Hematology, January 1, 2001; 2001(1): 259 - 281. [Abstract] [Full Text] [PDF] H. Stein, H.-D. Foss, H. Durkop, T. Marafioti, G. Delsol, K. Pulford, S. Pileri, and B. Falini CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features Blood, December 1, 2000; 96(12): 3681 - 3695. [Abstract] [Full Text] [PDF] M.-H. Delfau-Larue, L. Laroche, J. Wechsler, E. Lepage, C. Lahet, M. Asso-Bonnet, M. Bagot, and J.-P. Farcet Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma Blood, November 1, 2000; 96(9): 2987 - 2992. [Abstract] [Full Text] [PDF] R. S. Siegel, T. Pandolfino, J. Guitart, S. Rosen, and T. M. Kuzel Primary Cutaneous T-Cell Lymphoma: Review and Current Concepts J. Clin. Oncol., August 15, 2000; 18(15): 2908 - 2925. [Abstract] [Full Text] [PDF] J. R. Toro, M. Beaty, L. Sorbara, M. L. Turner, J. White, D. W. Kingma, M. Raffeld, and E. S. Jaffe {gamma}{delta} T-Cell Lymphoma of the Skin: A Clinical, Microscopic, and Molecular Study Arch Dermatol, August 1, 2000; 136(8): 1024 - 1032. [Abstract] [Full Text] [PDF] M. E. Kadin Cutaneous {gamma}{delta} T-Cell Lymphomas--How and Why Should They Be Recognized? Arch Dermatol, August 1, 2000; 136(8): 1052 - 1054. [Full Text] [PDF] E. Poszepczynska, M. Bagot, H. Echchakir, D. Martinvalet, M. Ramez, D. Charue, L. Boumsell, and A. Bensussan Functional characterization of an IL-7-dependent CD4+CD8alpha alpha + Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma Blood, August 1, 2000; 96(3): 1056 - 1063. [Abstract] [Full Text] [PDF] M. W. Bekkenk, F. A. M. J. Geelen, P. C. v. V. Vader, F. Heule, M.-L. Geerts, W. A. van Vloten, C. J. L. M. Meijer, and R. Willemze Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment Blood, June 15, 2000; 95(12): 3653 - 3661. [Abstract] [Full Text] [PDF] L. Cerroni, E. Arzberger, B. Putz, G. Hofler, D. Metze, C. A. Sander, C. Rose, P. Wolf, A. Rutten, J. M. McNiff, et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern Blood, June 15, 2000; 95(12): 3922 - 3928. [Abstract] [Full Text] [PDF] R. L t. Berge, J. J Oudejans, G.-J. Ossenkoppele, K. Pulford, R. Willemze, B. Falini, A. Chott, and C. J L M Meijer ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination J. Clin. Pathol., June 1, 2000; 53(6): 445 - 450. [Abstract] [Full Text] [PDF] T. L. Pandolfino, R. S. Siegel, T. M. Kuzel, S. T. Rosen, and J. Guitart Primary Cutaneous B-Cell Lymphoma: Review and Current Concepts J. Clin. Oncol., May 10, 2000; 18(10): 2152 - 2168. [Abstract] [Full Text] [PDF] R. van Doorn, C. W. Van Haselen, P. C. van Voorst Vader, M.-L. Geerts, F. Heule, M. de Rie, P. M. Steijlen, S. K. Dekker, W. A. van Vloten, and R. Willemze Mycosis Fungoides: Disease Evolution and Prognosis of 309 Dutch Patients Arch Dermatol, April 1, 2000; 136(4): 504 - 510. [Abstract] [Full Text] [PDF] M. Ming and P. E. LeBoit Can Dermatopathologists Reliably Make the Diagnosis of Mycosis Fungoides?: If Not, Who Can? Arch Dermatol, April 1, 2000; 136(4): 543 - 546. [Full Text] [PDF] J. Guitart, F. Roufosse, L. Schandene, E. Cogan, R. Suzuki, M. Seto, S. Nakaura, H.-U. Simon, and R. Dummer Idiopathic Eosinophilia N. Engl. J. Med., March 2, 2000; 342(9): 659 - 661. [Full Text] L. Heinzerling, R. Dummer, W. Kempf, M. H. Schmid, and G. Burg Intralesional Therapy With Anti-CD20 Monoclonal Antibody Rituximab in Primary Cutaneous B-Cell Lymphoma Arch Dermatol, March 1, 2000; 136(3): 374 - 378. [Abstract] [Full Text] [PDF]

	Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020